Valuation: Azenta, Inc.

Market Cap 1.4B 1.21B 1.13B 1.04B 1.95B 133B 1.99B 13.29B 5.22B 66.89B 5.27B 5.15B 221B P/E 2026 *
-8.9x
P/E 2027 * 146x
Enterprise Value 1.4B 1.21B 1.13B 1.04B 1.95B 133B 1.99B 13.29B 5.22B 66.89B 5.27B 5.15B 221B EV / Sales 2026 *
2.28x
EV / Sales 2027 * 2.18x
Free-Float
75.61%
Yield 2026 *
-
Yield 2027 * -
1 day+4.23%
1 week+13.90%
Current month+13.90%
1 month+26.29%
3 months+72.54%
6 months+11.56%
Current year-3.67%
1 week 27.76
Extreme 27.76
32.12
1 month 24.46
Extreme 24.455
32.12
Current year 15.93
Extreme 15.93
41.73
1 year 15.93
Extreme 15.93
41.73
3 years 15.93
Extreme 15.93
69.16
5 years 15.93
Extreme 15.93
124.79
10 years 12.05
Extreme 12.05
124.79
Manager TitleAgeSince
Chief Executive Officer 45 08/09/2024
Director of Finance/CFO 49 30/11/2024
Chief Tech/Sci/R&D Officer - 31/10/2009
Director TitleAgeSince
Director/Board Member 64 27/06/2013
Director/Board Member 50 02/04/2020
Chairman 72 29/01/2024
Date Insider Type Main position Quantity % Market Cap.
31/07/26 Buy

General Counsel

335 0.0007%
15/05/26 Tax

General Counsel

-3,621 0.0079%
28/04/26 Free

President Multiomics

17,790 0.0386%
Change 5-day change 1-year change 3-year change Capi.($)
+4.23%+13.90%+9.99%-32.45% 1.4B
+0.99%+1.78%+4.07%+16.73% 49.47B
+3.71%+9.40%+486.98%+592.14% 43.61B
+2.70%+1.57%+33.39%+8.85% 39.29B
+5.60%+10.21%+16.76%+85.72% 39.6B
+2.21%+6.75%+21.31%+53.37% 32.43B
+2.23%+4.71% - - 16.84B
+0.97%+2.35%+37.75%+126.84% 16.49B
-0.11%+2.41%+6.24%+18.87% 14.01B
+0.75%+15.04%+78.59%+30.30% 12.77B
Average +2.33%+7.08%+77.23%+100.04% 26.59B
Weighted average by Cap. +2.55%+6.14%+103.72%+139.81%

Financials

2026 *2027 *
Net sales 615M 532M 497M 456M 857M 58.53B 871M 5.83B 2.29B 29.34B 2.31B 2.26B 96.98B 642M 555M 518M 476M 894M 61.08B 909M 6.08B 2.39B 30.61B 2.41B 2.36B 101B
Net income -164M -141M -132M -121M -228M -15.57B -232M -1.55B -608M -7.8B -614M -601M -25.79B 20.35M 17.6M 16.44M 15.08M 28.36M 1.94B 28.81M 193M 75.7M 971M 76.42M 74.75M 3.21B
Net Debt - -
Logo Azenta, Inc.
Azenta, Inc. is a global provider of biological and chemical compound sample exploration and management solutions for the life sciences industry. The Company develops solutions for automated ultra-cold storage. It operates through two segments, which include Sample Management Solutions and Multiomics. The Sample Management Solutions segment operates as a single business unit offering end-to-end sample management products and services, including sample repository services and core products (automated stores, cryogenic systems, automated sample tube, consumables and instruments and controlled rate thawing devices). The Multiomics segment operates as a single business unit offering genomic and other sample analysis services, including gene sequencing, gene synthesis and related services. It offers a portfolio of products and sample services including procurement, automated storage systems, genomic services and a multitude of sample consumables, informatics and data software.
Employees
3,000
Date Price Change Volume
07/08/26 US$32.04 +4.23% 735,875
06/08/26 US$30.74 -3.39% 750,323
05/08/26 US$31.82 +5.61% 1,108,242
04/08/26 US$30.13 +0.84% 894,557
03/08/26 US$29.88 +6.22% 1,111,270
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
32.04USD
Average target price
34.80USD
Spread / Average Target
+8.61%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AZTA Stock